Current out of pocket care costs among HIV and hypertension co-morbid patients in urban and peri-urban Uganda.


Journal

PLOS global public health
ISSN: 2767-3375
Titre abrégé: PLOS Glob Public Health
Pays: United States
ID NLM: 9918283779606676

Informations de publication

Date de publication:
2024
Historique:
received: 16 02 2024
accepted: 28 07 2024
medline: 25 9 2024
pubmed: 25 9 2024
entrez: 25 9 2024
Statut: epublish

Résumé

Despite improvements to the cascade of HIV care in East Africa, access to care for non-communicable disease co-morbidities like hypertension (HTN) remains a persistent problem. The integration of care for these conditions presents an opportunity to achieve efficiencies in delivery as well as decrease overall costs for patients. This study aims to build evidence on the burden of current out-of-pocket costs of care among HIV-HTN co-morbid patients. We administered a pre-tested, cross-sectional, out-of-pocket cost survey to 94 co-morbid patients receiving HIV care from 10 clinics in the Wakiso and Kampala districts of Uganda from June to November 2021. The survey assessed socio-demographic characteristics, direct medical costs (e.g., medications, consultations), indirect costs (e.g., transport, food, caregiving), and economic costs (i.e., foregone income) associated with seeking HIV and HTN care, as well as possible predictors of monthly care costs. Patients were sampled both during a government-imposed nation-wide full COVID-19 lockdown (n = 30) and after it was partially lifted (n = 64). Median HIV care costs constitute between 2.7 and 4.0% of median monthly household income, while HTN care costs are between 7.1 to 7.9%. For just under half of our sample, the median monthly cost of HTN care is more than 10% of household income, and more than a quarter of patients report borrowing money or selling assets to cover costs. We observe uniformly lower reported costs of care for both conditions under full COVID-19 lockdown, suggesting that access to care was limited. The main predictors of monthly HIV and HTN care costs varied by disease and costing perspective. Patient out of pocket costs of care for HIV and HTN were substantial, but significantly lower during the 2021 full COVID-19 lockdown in Uganda. New strategies such as service integration need to be explored to reduce these costs.

Sections du résumé

BACKGROUND BACKGROUND
Despite improvements to the cascade of HIV care in East Africa, access to care for non-communicable disease co-morbidities like hypertension (HTN) remains a persistent problem. The integration of care for these conditions presents an opportunity to achieve efficiencies in delivery as well as decrease overall costs for patients. This study aims to build evidence on the burden of current out-of-pocket costs of care among HIV-HTN co-morbid patients.
METHODS METHODS
We administered a pre-tested, cross-sectional, out-of-pocket cost survey to 94 co-morbid patients receiving HIV care from 10 clinics in the Wakiso and Kampala districts of Uganda from June to November 2021. The survey assessed socio-demographic characteristics, direct medical costs (e.g., medications, consultations), indirect costs (e.g., transport, food, caregiving), and economic costs (i.e., foregone income) associated with seeking HIV and HTN care, as well as possible predictors of monthly care costs. Patients were sampled both during a government-imposed nation-wide full COVID-19 lockdown (n = 30) and after it was partially lifted (n = 64).
RESULTS RESULTS
Median HIV care costs constitute between 2.7 and 4.0% of median monthly household income, while HTN care costs are between 7.1 to 7.9%. For just under half of our sample, the median monthly cost of HTN care is more than 10% of household income, and more than a quarter of patients report borrowing money or selling assets to cover costs. We observe uniformly lower reported costs of care for both conditions under full COVID-19 lockdown, suggesting that access to care was limited. The main predictors of monthly HIV and HTN care costs varied by disease and costing perspective.
CONCLUSIONS CONCLUSIONS
Patient out of pocket costs of care for HIV and HTN were substantial, but significantly lower during the 2021 full COVID-19 lockdown in Uganda. New strategies such as service integration need to be explored to reduce these costs.

Identifiants

pubmed: 39321165
doi: 10.1371/journal.pgph.0003423
pii: PGPH-D-24-00258
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e0003423

Informations de copyright

Copyright: © 2024 Cameron et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interest exist.

Auteurs

Drew B Cameron (DB)

Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut, United States of America.

Lillian C Morrell (LC)

Center for Global Noncommunicable Diseases, RTI International, Seattle, Washington, United States of America.

Faith Kagoya (F)

Infectious Disease Research Collaboration, Kampala, Uganda.

John Baptist Kiggundu (JB)

Infectious Disease Research Collaboration, Kampala, Uganda.

Brian Hutchinson (B)

Center for Global Noncommunicable Diseases, RTI International, Seattle, Washington, United States of America.

Robert Twine (R)

Infectious Disease Research Collaboration, Kampala, Uganda.

Jeremy I Schwartz (JI)

Section of General Internal Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America.
Uganda Initiative for Integrated Management of Non-Communicable Diseases, Kampala, Uganda.

Martin Muddu (M)

Makerere University Joint AIDS Program, Kampala, Uganda.

Gerald Mutungi (G)

Uganda Ministry of Health, Kampala, Uganda.

James Kayima (J)

Uganda Heart Institute, Kampala, Uganda.
Department of Internal Medicine, Makerere University Kampala, Kampala, Uganda.

Anne R Katahoire (AR)

Child Health and Development Centre, Makerere University College of Health Sciences, School of Medicine, Kampala, Uganda.

Chris T Longenecker (CT)

Division of Cardiology, Department of Global Health, University of Washington, Seattle, Washington, United States of America.

Rachel Nugent (R)

Center for Global Noncommunicable Diseases, RTI International, Seattle, Washington, United States of America.

David Contreras Loya (DC)

Tecnológico de Monterrey, Monterrey, México.

Fred C Semitala (FC)

Infectious Disease Research Collaboration, Kampala, Uganda.
Makerere University Joint AIDS Program, Kampala, Uganda.
Department of Internal Medicine, Makerere University Kampala, Kampala, Uganda.

Classifications MeSH